• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION LUX-DX INSERTABLE CARDIAC MONITOR; RECORDER, EVENT, IMPLANTABLE CARDIAC, (WITH ARRHYTHMIA DETECTION)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION LUX-DX INSERTABLE CARDIAC MONITOR; RECORDER, EVENT, IMPLANTABLE CARDIAC, (WITH ARRHYTHMIA DETECTION) Back to Search Results
Model Number M301
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Hemorrhage/Bleeding (1888)
Event Date 11/21/2023
Event Type  Injury  
Event Description
It was reported that this insertable cardiac monitor (icm) device was explanted.The physician alerted the boston scientific representative that days after the icm device implant procedure the patient was seen at the emergency room.The bandage over the incision site was soaked with blood.The patient was subsequently seen at the clinic.The clinic removed the bandage and found the incision was open.The physician chose to explant the icm device and start the patient on antibiotics.The physician plans to implant a new icm device in two weeks.The device was not returned for analysis.No additional adverse patient effects were reported.
 
Event Description
It was reported that days after the insertable cardiac monitor (icm) device implant procedure the patient was seen at the emergency room.The bandage over the incision site was soaked with blood.The patient was subsequently seen at the clinic.The clinic removed the bandage and found the incision was open.The physician chose to explant the icm device and start the patient on antibiotics.The physician plans to implant a new icm device in two weeks.The device has been returned for analysis.No other devices have been implanted at this time.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This icm was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device identified no anomalies.Testing was completed to assess sensing and device functionality.Measurements throughout these tests were within normal limits.Detailed analysis suggests clinical observations are a known medical risk.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUX-DX INSERTABLE CARDIAC MONITOR
Type of Device
RECORDER, EVENT, IMPLANTABLE CARDIAC, (WITH ARRHYTHMIA DETECTION)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key18218832
MDR Text Key329144737
Report Number2124215-2023-67148
Device Sequence Number1
Product Code MXD
UDI-Device Identifier00802526607103
UDI-Public00802526607103
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193473
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/28/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/14/2024
Device Model NumberM301
Device Catalogue NumberM301
Device Lot Number165305
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/18/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/08/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age58 YR
-
-